Skip to main content

and
  1. Article

    A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo Response

    One of the main reasons for the inefficiency of multicenter randomized clinical trials (RCTs) in depression is the excessively high level of placebo response. The aim of this work was to propose a novel method...

    Roberto Gomeni, Navin Goyal, Françoise Bressolle, Maurizio Fava in Neuropsychopharmacology (2015)

  2. Article

    A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

    Christine Plard, Françoise Bressolle, May Fakhoury in Cancer Chemotherapy and Pharmacology (2007)

  3. No Access

    Article

    A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

    The objectives of this study were to characterize the population pharmacokinetics of MTX in patients with acute lymphoblastic leukemia (ALL) with ages ranging from 2 to 16 years and to propose a limited sampli...

    Christine Piard, Françoise Bressolle, May Fakhoury in Cancer Chemotherapy and Pharmacology (2007)

  4. No Access

    Article

    Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen

    Purpose: Irinotecan is extensively metabolized into at least four compounds and previous pharmacokinetic–pharmacodynamic studies have given varying results. We hypothesized that saliva, a...

    Sylvain Poujol, Françoise Bressolle in Cancer Chemotherapy and Pharmacology (2006)

  5. No Access

    Article

    Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies

    The objective of the present study was to characterize the population pharmacokinetics of melphalan infused over a 24-h period in patients with advanced malignancies.

    Philippe Mougenot, Frédéric **uet, Michel Fabbro in Cancer Chemotherapy and Pharmacology (2004)

  6. No Access

    Article

    Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

    The aim of this phase II study was to determine the efficacy and tolerability of the bimonthly, pharmacokinetically intensified LV5FU2 regimen in the treatment of metastatic colorectal cancers.

    Marc Ychou, Jacqueline Duffour, Andrew Kramar in Cancer Chemotherapy and Pharmacology (2003)

  7. No Access

    Article

    Pharmacokinetic-Pharmacodynamic Modelling of Ketamine in Six Neurotraumatised Intensive Care Patients

    Youssef Hijazi, Carole Bodonian, François Salord in Clinical Drug Investigation (2003)

  8. No Access

    Article

    Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer

    Purpose: As vinorelbine is 78% bound to platelets, it seems interesting to investigate the pharmacokinetic profile of this drug from blood and to compare it to that determined from plasma. Thus, in this study, t...

    Amélie Gauvin, Frédéric **uet, Stéphane Culine in Cancer Chemotherapy and Pharmacology (2002)

  9. No Access

    Article

    Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer

    Purpose: The purpose of this work was to estimate the population pharmacokinetic parameters of 5-fluorouracil (5-FU) in patients with advanced colorectal cancer using circadian change kinetics. Methods: Eighty-f...

    Françoise Bressolle, Jean M. Joulia in Cancer Chemotherapy and Pharmacology (1999)

  10. No Access

    Article

    Predictive Performance of a Semiparametric Method to Estimate Population Pharmacokinetic Parameters Using NONMEM

    Routine clinical pharmacokinetic (PK) data collected from patients receiving inulin were analyzed to estimate population PK parameters; 560 plasma concentration determinations for inulin were obt...

    Françoise Bressolle, Roberto Gomeni in Journal of Pharmacokinetics and Biopharmaceutics (1998)

  11. No Access

    Article

    Time-dependent Pharmacokinetics of High Dose Thiopental Infusion in Intensive Care Patients

    Purpose. In patients with severe head injuries receiving long-term infusion for reducing intracranial pressure, a decline in concentrations was apparent following attainment of an initial steady state. This coul...

    Hélène Russo, Marie P. Dubboin, Françoise Bressolle, Saïk Urien in Pharmaceutical Research (1997)

  12. No Access

    Article

    Methyl-β-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin

    The purpose of this work was to determine the role of methyl-β-cyclodextrin (MEBCD) in combination with doxorubicin (DOX) on the cellular proliferation of a sensitive parental and a multidrug-resistant human ...

    Pierre-Yves Grosse, Françoise Bressolle in Cancer Chemotherapy and Pharmacology (1997)

  13. No Access

    Article

    Comparison of a Direct and Indirect Population Pharmacodynamic Model: Application to Recombinant Human Erythropoietin in Athletes

    Basic physiologic indirect response models have been proposed to account for the pharmacodynamics of drugs that act by way of inhibition or stimulation of the production or loss of endogenous sub...

    Françoise Bressolle, Michel Audran in Journal of Pharmacokinetics and Biopharmac… (1997)

  14. No Access

    Article

    Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review

    Véronique Pinzani, Françoise Bressolle in Cancer Chemotherapy and Pharmacology (1994)

  15. No Access

    Article

    Multiple-Dose Pharmacokinetics of Pefloxacin in Patients with Hepatocellular Deficiency

    Multiple-dose pharmacokinetics of pefloxacin were evaluated in 25 patients with hepatocellular insufficiency. The severity of liver disease was graded A, B or C according to the Child-Pugh classification. Phar...

    Marc Galtier, Françoise Bressolle in Clinical Pharmacokinetics (1993)

  16. No Access

    Article

    Identification of Patients with Impaired Hepatic Drug Metabolism Using a Limited Sampling Procedure for Estimation of Phenazone (Antipyrine) Pharmacokinetic Parameters

    Phenazone (antipyrine) 1g was given by short intravenous infusion to 62 study participants (10 healthy drug-free volunteers and 52 patients with chronic liver disease). A Bayesian approach was developed to det...

    David Fabre, Françoise Bressolle, Roberto Goméni in Clinical Pharmacokinetics (1993)

  17. No Access

    Article

    Doxorubicin and doxorubicinol plasma concentrations and excretion in parotid saliva

    The pharmacokinetics of doxorubicin (DOX) and doxorubicinol (DOXol) was studied in six patients with various advanced neoplastic diseases who received 28–72 mg/m2 DOX (nine courses). Plasma and parotid saliva wer...

    Françoise Bressolle, Jeanne-Marie Jacquet in Cancer Chemotherapy and Pharmacology (1992)

  18. No Access

    Article

    Doxorubicin and doxorubicinol: intra-and inter-individual variations of pharmacokinetic parameters

    Doxorubicin was given by short i. v. infusion (dose range 25–72 mg/m2) to 18 patients who underwent three to seven successive courses of chemotherapy (total, 57 courses). Plasma levels of doxorubicin and its majo...

    Jeanne-Marie Jacquet, Françoise Bressolle in Cancer Chemotherapy and Pharmacology (1990)